# A 35-year-old patient with newly diagnosed hypertension has a blood pressure of 158/98 mmHg. The healthcare provider has prescribed lisinopril 10 mg daily. What is the most important nursing intervention when initiating ACE inhibitor therapy? > source: MyMerci (mymerci.kr) > url: https://mymerci.kr/pages/nclex_q.php?qn_id=540323 > language: ko > subject: Adult Health ## 문제 A 35-year-old patient with newly diagnosed hypertension has a blood pressure of 158/98 mmHg. The healthcare provider has prescribed lisinopril 10 mg daily. What is the most important nursing intervention when initiating ACE inhibitor therapy? ## 보기 1. Monitor for orthostatic hypotension and educate about position changes **✔ 정답** 2. Encourage increased sodium intake to prevent hypotension 3. Administer the medication with food to enhance absorption 4. Instruct the patient to take the medication only when blood pressure is elevated **정답: 1** ## 해설 ACE inhibitors like lisinopril can cause orthostatic hypotension, so monitoring and educating about position changes is crucial to prevent falls. Other options like increasing sodium intake or taking medication only when BP is elevated are incorrect. ## 심화 해설 NCLEX-RN Clinical Application: Initiating ACE Inhibitor Therapy When starting a patient on an angiotensin-converting enzyme (ACE) inhibitor such as lisinopril, the most critical nursing intervention is to monitor for orthostatic hypotension and educate about position changes. This priority stems directly from the drug's mechanism of action and the predictable physiological response during the initial treatment phase. ACE inhibitors block the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. This leads to arteriolar and venous dilation, reducing systemic vascular resistance and blood pressure. The first dose can cause a pronounced drop in blood pressure, a phenomenon known as first-dose hypotension, which is particularly dangerous when a patient moves from a supine or sitting position to standing. The resulting orthostatic hypotension significantly increases the risk of syncope, falls, and injury. As highlighted in the current hypertension guidelines, a pragmatic, primary care-focused approach to managing hypertension necessitates anticipating and mitigating such adverse effects to ensure patient safety and medication adherence [1,2]. The rationale for this intervention is further reinforced by evidence from heart failure management, where ACE inhibitors and angiotensin receptor-neprilysin inhibitors (ARNIs) are cornerstones of guideline-directed medical therapy (GDMT). A major barrier to initiating and up-titrating these life-saving medications is the occurrence of hypotension. Clinical reports indicate that hypotension is a common reason for delayed initiation, dose reduction, or discontinuation of therapy, which directly undermines treatment goals [3]. By proactively monitoring for this effect, the nurse plays a pivotal role in enabling the patient to safely reach and maintain their target dose. The other options are incorrect and potentially harmful. Encouraging increased sodium intake directly contradicts the dietary modifications essential for hypertension management, which aim to lower blood pressure. Administering lisinopril with food is not required for absorption and does not mitigate the risk of first-dose hypotension. Most critically, instructing a patient to take the medication only when blood pressure is elevated promotes dangerous fluctuations in blood pressure and negates the protective, long-term cardiovascular benefits of consistent therapy. The goal of treatment is to maintain a controlled, steady-state blood pressure, not to chase intermittent spikes. The consistent underutilization of GDMT observed in various settings underscores the importance of nurses not only administering the medication but also actively managing the barriers, like hypotension, that lead to treatment gaps . The priority nursing action is to obtain a baseline blood pressure and heart rate, administer the dose, and then monitor the patient's response, particularly after the first dose. Specific education must include instructing the patient to rise slowly from a lying to a sitting position, pause for a moment, and then stand up gradually. They should be taught to recognize symptoms of hypotension such as dizziness or lightheadedness and to sit or lie down immediately if these occur. This anticipatory guidance is fundamental to safe initiation of ACE inhibitor therapy.References (research sources) - [3]Expert Opinion on Optimising Guideline-Directed Medical Therapy and Expanding the Role of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) for Heart Failure Management in India.GuidelinePandey BP, Ray S, Kumar S, Guha S, Desai BN, Shah MK, Kudva S, Chopra VK, Agarwal R, Rastogi V, Ponde CK, Sharma RK, Pawar D, Chavan G, Kolapkar V. (2026) · DOI: 10.7759/cureus.107772 ## 임상 시나리오 Initiating ACE Inhibitor TherapyPreventing First-Dose Orthostatic Hypotension The highest priority when starting an ACE inhibitor like lisinopril is monitoring for orthostatic hypotension. This adverse effect is most pronounced after the first dose due to sudden vasodilation. Instruct the patient to change positions slowly, dangling legs at the bedside before standing. Advise them to sit or lie down immediately if they feel dizzy. A significant drop is defined as a systolic decrease of at least 20 mmHg or a diastolic decrease of at least 10 mmHg upon standing. CautionNever advise patients to increase sodium intake or take the medication only when symptomatic. Consistent daily administration is required for effective blood pressure control, and added sodium counteracts the drug's effect. ## 핵심 개념 - **First-dose hypotension** — A sudden, marked drop in blood pressure that can occur after the initial dose of an ACE inhibitor due to abrupt vasodilation. - **Orthostatic hypotension** — A form of low blood pressure that happens when standing up from sitting or lying down, causing dizziness or syncope. - **ACE inhibitor** — A class of medication that blocks the angiotensin-converting enzyme, leading to vasodilation and reduced blood pressure. - **Angiotensin II** — A potent vasoconstrictor hormone whose production is decreased by ACE inhibitors, lowering systemic vascular resistance. ## 같은 주제 문제 - [A nurse is assessing a 65-year-old client with newly diagnosed hypertension. Which assessm…](https://mymerci.kr/pages/nclex_q.php?qn_id=540320) - [A nurse is assessing a 45-year-old client with newly diagnosed hypertension. Which assessm…](https://mymerci.kr/pages/nclex_q.php?qn_id=540321) - [A nurse is assessing a 61-year-old client with a history of hypertension who presents to t…](https://mymerci.kr/pages/nclex_q.php?qn_id=540322) - [A nurse is caring for a 52-year-old client with newly diagnosed stage 1 hypertension (bloo…](https://mymerci.kr/pages/nclex_q.php?qn_id=540324) --- More free questions: [기출문제](https://mymerci.kr/) _학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요._